Angidac Sept, 0.15% solution 150 ml

NSAIDS. The mechanism of action is associated with inhibition of COX enzyme and disruption of prostaglandin synthesis.

Indications

For local use in ENT practice and dentistry: inflammatory diseases of the oral cavity and throat, as an additional remedy for conservative therapy after tooth extraction, after surgical interventions and injuries (tonsillectomy, jaw fractures), calculous inflammation of the salivary glands.

For local use in obstetrics and gynecology: in the postpartum period for the prevention of postpartum infectious complications, specific vulvovaginitis (as part of complex therapy), nonspecific vulvovaginitis and cervicovaginitis of any etiology (including those secondary to chemotherapy and radiotherapy), bacterial vaginosis, prevention of postoperative infectious complications in surgical gynecology.

Pharmacological effect

NSAIDs. The mechanism of action is associated with inhibition of the COX enzyme and disruption of prostaglandin synthesis.

Special instructions

It is not recommended for use as a mouth rinse in children under 12 years of age.

Used as part of combination drugs.

Active ingredient

Benzydamine

Composition

The solution for topical use is colorless or slightly yellowish, transparent, with a characteristic mint odor.

1 ml
benzydamine hydrochloride
1.5 mg

Excipients:

ethanol (ethyl alcohol 95%) – 80.84 mg,

glycerin – 50 mg,

methyl parahydroxybenzoate – 1 mg,

menthol flavoring – 0.3 mg,

sodium saccharinate – 0.24 mg,

sodium bicarbonate – 0.11 mg,

polysorbate 20 – 0.05 mg,

sodium hydroxide solution 1M or hydrochloric acid solution 0.5M – up to pH 5.0-7.0,

water for d/i – up to 1 ml.

Contraindications

Hypersensitivity to benzydamine.

Side Effects

Possible: allergic reactions, burning sensation.

Recommendations for use

Apply topically 1-2 times/day.

Manufacturer

Grotex LLC, Russia